Week 4: APL and supportive care Flashcards

1
Q

What is this?

A

Disseminated intravascular coagulation; oncologic emergency indicative of APL (M3 AML)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the treatment of APL?

A

All-trans retinoic acid (directly addresses maturation block)

Arsinic tri-oxide (induces degradation of chimeric protein, induces apoptosis at higher doses)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the three contexts that nausea is considered?

A

Anticipatory, acute, delayed (>24 hours)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the central pathway of nausea and vomiting involved in? Where is it located?

A

Involved in the delayed phase of chemotherapy-induced nausea and vomiting; Primarily in the brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the peripheral pathway of nausea and vomiting involved in? Where is it located?

A

Predominantly involved in the acute phase of chemotherapy-induced nausea and vomiting; Found in GI tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the “Old School” drugs that can be helpful for nausea/vomiting?

A

ABCD: ativan (lorazepam), Benadryl (diphehydramine), Compazine (mostly olanzapine), Dexamethasone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does NK1-receptor antagonists do in terms of nausea/vomiting? Where does it act?

A

Acts in brain to block substance P release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What do 5-HT3 receptor antagonists do in terms of nausea and vomiting? Where do they act?

A

Prevent binding of Serotonin onto vagal nerve in GI tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the cancers that primarily form blood clots?

A

Pancreas, breast, prostate, bladder, lung and CNS cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the markers of hypercoagulability that are associated with poor survival?

A

elevated D-dimer, elevated INR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is considered in the assessment of DVT risk?

A

site of cancer, platelet count, low Hgb, leukocyte count, BMI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What drug is the best to use for management of DVT in cancer?

A

low-molecular weight heparin (LMWH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why are bones so attractive for mets?

A

contains many growth factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the cancers that mostly affect bone?

A

Breast and prostate cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What cancers respond to bone-directed treatment?

A

Meyloma, Breast and Renal Cell (NOT PROSTATE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the mechanism of bisphosphanates?

A

Prevents the loss of bone mass

17
Q

What is the most potent bisphosphanate?

A

Zoledronic acid

18
Q

What is zoledronic acid?

A

bisphosphonate used to prevent the resorption of bone

19
Q

What is treatment of constipation?

A

polyethylene glycol, mineral oil (lubricant)

20
Q

When writing a prescription for narcotics, what should you always discuss specific measures for?

A

constipation

21
Q

What should you remember during the treatment of diarrhea?

A

electrolye replacement, fiber supplementation

22
Q

What are treatments for diarrhea?

A

Tincture of opium, somatostatin analogues

23
Q

What drug can be given to prevent myelosuppression?

A

Granulocyte colony stimulating factor (G-CSF)

24
Q

What can present in young people receiving moderate myelosuppressive therapy?

A

long-acting form causes bad low back pain that may present to the ER

25
Q

T/F: pushing Hgb above 10 with EPO is associated with worse outcomes

A

True

26
Q

Should EPO be used for chemotherapy patients?

A

No; restricted to transfusino-dependent marrow failure

27
Q

What are eltrombopag and romiplostim?

A

thrombopoietin receptor agonists